Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CalciMedica Inc CALC

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.


NDAQ:CALC - Post by User

User Avatar Image
(169)
•••
  • yukon_goldX
Post by yukon_goldon Jan 30, 2023 11:23pm
521 Views
Post# 35255610

Graycliff's Interview with Planet MicroCap for Latest Update

Graycliff's Interview with Planet MicroCap for Latest Update

WATCH BELOW:

 

CEO James Macintosh Talks Graycliff's Shakespeare and Baldwin Gold Projects in Ontario and 2023 Value Catalysts

Watch the latest interview for a brief overview and history of Graycliff Exploration, learn what makes Graycliff's gold projects stand out from its peers, and the Company's value catalysts in the near term and the year ahead.

Graycliff Exploration Limited (CSE: GRAY) Webcast | Planet MicroCap Showcase: VIRTUAL 2022

Click on the video above to watch the interview or find the video link below:

https://youtu.be/uKPO1VcZu60

 
About Graycliff Exploration Limited
 
Graycliff Exploration is a mineral exploration company focused on its 1,025 hectares of prospective ground, located roughly 80 kilometres west of Sudbury on the prolific Canadian Shield. The Company's Shakespeare Project consists of one crown patented lease, two crown leases and 40 claims on a property associated with the historic Shakespeare Gold Mine, which operated from 1903 to 1907. Graycliff’s Baldwin Project is adjacent to the east and is comprised of 68 claims covering 1,500 hectares. This brings the Company's total land package in the area to 2,525 hectares. The two projects together could be the beginning of a new Ontario Gold Camp.
 

For more information, please contact:

 

 

Iryna Zheliasko, Investor Relations

Iryna@grovecorp.ca

1-647-249-9298

Visit our website
Graycliff Exploration Limited
Nicholas D Konkin | 401 Bay Street, Suite 2702, 401 Bay Street, Suite 2702, Toronto, M5H2Y4 Canada 4165679087
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities